Adipokines in NASH:: Postprandial lipid metabolism as a link between adiponectin and liver disease

被引:209
作者
Musso, G
Gambino, R
Durazzo, M
Biroli, G
Carello, M
Fagà, E
Pacini, G
De Michieli, F
Rabbione, L
Premoli, A
Cassader, M
Pagano, G
机构
[1] Univ Turin, Dipartimento Med Interna, I-10126 Turin, Italy
[2] CNR, Metab Unit, Inst Biomed Engn, ISIB, Padua, Italy
关键词
D O I
10.1002/hep.20896
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Circulating levels of four adipokines (adiponectin, TNF-alpha, leptin, and resistin) and the postprandial lipid and adiponectin responses to an oral fat load were assessed in 25 non-obese, non-diabetic patients with biopsy-proven nonalcoholic steatohepatitis (NASH) and correlated with metabolic indices and liver histology. Circulating adiponectin was lower in NASH compared with controls (5,476 +/- 344 vs. 11,548 +/- 836 ng/mL; P =.00001) and on multiple regression analysis correlated negatively with liver steatosis, necroinflammation (OR = 5.0; P =.009), and fibrosis (OR = 8.0; P =.003). The magnitude of postprandial lipemia was significantly higher in NASH than in controls and was related to fasting adiponectin (beta = -0.78; P =.00003). Controls showed a significant increase in serum adiponectin in response to the fat load, whereas patients with NASH showed a slight decrease. Postprandial free fatty acids response correlated inversely with adiponectin response in both groups and independently predicted the severity of liver steatosis in NASH (13 = 0.51; P =.031). In conclusion, hypoadiponectinemia is present before overt diabetes and obesity appear and correlates with the severity of liver histology in NASH. Impaired postprandial lipid metabolism may be an additional mechanism linking hypoadiponectinemia and NASH and posing a higher cardiovascular risk to these subjects. The mechanism(s) underlying these differences are unknown, but the type of dietary fat seems to play a role. These findings may have important pathogenetic and therapeutic implications in both liver and metabolic disease.
引用
收藏
页码:1175 / 1183
页数:9
相关论文
共 48 条
[1]   Leptin, insulin resistance, and liver fibrosis in human nonalcoholic fatty liver disease [J].
Angulo, P ;
Alba, LM ;
Petrovic, LM ;
Adams, LA ;
Lindor, KD ;
Jensen, MD .
JOURNAL OF HEPATOLOGY, 2004, 41 (06) :943-949
[2]   Investigation of in vivo fatty acid metabolism in AFABP/aP2-/- mice [J].
Baar, RA ;
Dingfelder, CS ;
Smith, LA ;
Bernlohr, DA ;
Wu, CD ;
Lange, AJ ;
Parks, EJ .
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2005, 288 (01) :E187-E193
[3]   Adiponectin relationship with lipid metabolism is independent of body fat mass:: Evidence from both cross-sectional and intervention studies [J].
Baratta, R ;
Amato, S ;
Degano, C ;
Farina, MG ;
Patanè, G ;
Vigneri, R ;
Frittitta, L .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2665-2671
[4]   Acute regulation of adiponectin by free fatty acids [J].
Bernstein, EL ;
Koutkia, P ;
Ljungquist, K ;
Breu, J ;
Canavan, B ;
Grinspoon, S .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (06) :790-793
[5]   Second world congress on the insulin resistance syndrome - Insulin resistance syndrome and nonalcoholic fatty liver disease [J].
Bloomgarden, ZT .
DIABETES CARE, 2005, 28 (06) :1518-1523
[6]   Insulin and endothelin in the acute regulation of adiponectin in vivo in humans [J].
Brame, LA ;
Considine, RV ;
Yamauchi, M ;
Baron, AD ;
Mather, KJ .
OBESITY RESEARCH, 2005, 13 (03) :582-588
[7]   Nonalcoholic steatohepatitis: Definition and pathology [J].
Brunt, EM .
SEMINARS IN LIVER DISEASE, 2001, 21 (01) :3-16
[8]  
Carnovale E.M., 1997, TABELLA COMPOSIZIONE
[9]  
Chalasani N, 2003, AM J GASTROENTEROL, V98, P2771, DOI [10.1016/j.amjgastroenterol.2003.09.037, 10.1111/j.1572-0241.2003.08767.x]
[10]   Serum leptin in NASH correlates with hepatic steatosis but not fibrosis: A manifestation of lipotoxicity? [J].
Chitturi, S ;
Farrell, G ;
Frost, L ;
Kriketos, A ;
Lin, R ;
Liddle, C ;
Samarasinghe, D ;
George, J .
HEPATOLOGY, 2002, 36 (02) :403-409